Suvanza Pharma, LLC (OTCPK: SUVZ)
Health Care · Biotechnology · US
$—
— today · — 1Y
Suvanza Pharma, LLC (OTCPK: SUVZ) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.24K and employs 0 people.
trading between 0.00 and 0.00.
SUVZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.24K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.77
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.20M
- Employees
- 0
- Next earnings
- —
About Suvanza Pharma, LLC
Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in 2004 and is headquartered in Miami Beach, Florida, officially changed its name from Hamilton PNG to Suvanza Pharma, LLC in March 2010.
- ISIN
- US8695511019
- Founded
- 2004
- Listed since
- Feb 24, 1995
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.97 | +0.58% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €883.80 | -2.02% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $142.62 | -1.69% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.